HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M G Benghanem Selected Research

alfacalcidol

6/2006A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M G Benghanem Research Topics

Disease

2Chronic Kidney Failure (Chronic Renal Failure)
06/2006 - 01/2005
2Hyperparathyroidism
06/2006 - 01/2003
1Acidosis
03/2022
1Hyperkalemia
03/2022
1Hypotension (Low Blood Pressure)
09/2007
1Secondary Hyperparathyroidism
06/2006
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2005
1Ossifying Fibroma
01/2003

Drug/Important Bio-Agent (IBA)

1SodiumIBA
03/2022
1Dialysis SolutionsIBA
09/2007
1alfacalcidolIBA
06/2006
1Calcitriol (Calcijex)FDA LinkGeneric
06/2006
1Phosphates (Orthophosphate)IBA
06/2006
1Vitamin DFDA LinkGeneric
06/2006

Therapy/Procedure

3Renal Dialysis (Hemodialysis)
03/2022 - 01/2003
1Therapeutics
06/2006